Filing Details

Accession Number:
0001209191-17-058227
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-27 19:40:26
Reporting Period:
2017-10-27
Accepted Time:
2017-10-27 19:40:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437786 Immune Design Corp. IMDZ Pharmaceutical Preparations (2834) 262007174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1606074 Peter Svennilson C/O Immune Design Corp.
1616 Eastlake Avenue. E., Suite 310
Seattle WA 98102
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-27 2,681,000 $4.10 2,681,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 800,000 Indirect See Footnote
Common Stock 3,161,942 Indirect See Footnote
Footnotes
  1. The securities are directly held by Ponoi Capital, LP ("Ponoi Capital") and indirectly held by Ponoi Management, LLC ("Ponoi Management"), the general partner of Ponoi Capital. Ponoi Management has voting and dispositive power with respect to the shares owned by Ponoi Capital. Mr. Svennilson is a managing partner of Ponoi Management and may be deemed to have shared voting and dispositive power over the shares owned by Ponoi Capital. Mr. Svennilson disclaims beneficial ownership of all shares held by Ponoi Capital, except to the extent of his actual pecuniary interest therein.
  2. The securities are directly held by The Column Group II, LP ("The Column Group II") and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of The Column Group II. TCG II GP has voting and dispositive power with respect to the shares owned by The Column Group II. Mr. Svennilson is a managing partner of TCG II GP and may be deemed to have shared voting and dispositive power over the shares owned by The Column Group II. Mr. Svennilson disclaims beneficial ownership of all shares held by The Column Group II, except to the extent of his actual pecuniary interest therein.
  3. The securities are directly held by The Column Group, LP ("The Column Group") and indirectly held by The Column Group GP, LP ("TCG GP"), the general partner of The Column Group. TCG GP has voting and dispositive power with respect to the shares owned by The Column Group. Mr. Svennilson is a managing partner of TCG GP and may be deemed to have shared voting and dispositive power over the shares owned by The Column Group. Mr. Svennilson disclaims beneficial ownership of all shares held by The Column Group, except to the extent of his actual pecuniary interest therein.